Surgery for recurrent inflammatory pseudotumor of the lung

World Journal of Surgical Oncology

Case Report

Ryoichi Kato¹  Taichiro Goto¹  Kumi Akanabe¹  Arafumi Maeshima² 

[1] Department of General Thoracic Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan;Department of Pathology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan;

关键词: Germinal Center;    Wedge Resection;    Fibrous Histiocytoma;    Nodular Lesion;    Infiltrative Lesion;   

DOI  :  10.1186/1477-7819-9-133

 received in 2011-05-10, accepted in 2011-10-18,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundCases of recurrent inflammatory pseudotumor have only rarely been reported. The treatment for recurrent pseudotumor is surgery. Patients not eligible for surgery require different treatment, and the optimal type of the treatment is controversial.Case PresentationA 54-year-old woman was noted to have an abnormal shadow in the right middle lung field on chest X-ray. Computed tomography of the chest revealed an infiltrative lesion in the right segment 4 and a nodule in the right segment 8. She underwent right middle lobectomy and partial resection of the right segment 8. Histopathology revealed non-atypical lymphocytes and plasma cells infiltrates, leading to the diagnosis of the lymphoplasmacytic type of inflammatory pseudotumor. During postoperative follow-up, chest computed tomography revealed a nodular lesion in the left segment 3 and an infiltrative lesion in the right segment 2. Left segment 3 segmentectomy and right segment 2 wedge resection were performed. The histopathological findings were similar to those of the first surgical specimen, leading to the diagnosis of recurrent lymphoplasmacytic type of inflammatory pseudotumor.ConclusionSurgical cases of recurrent inflammatory pseudotumor of the lung have been reported only very rarely. We believe that surgery is the best treatment for recurrent inflammatory pseudotumor of the lung when patients are eligible.

【 授权许可】

CC BY   
© Goto et al; licensee BioMed Central Ltd. 2011